USP25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.712400E-01
Normal-vs-Stage2
1.784030E-01
Normal-vs-Stage3
4.137600E-02
Normal-vs-Stage4
4.145800E-01
Stage1-vs-Stage2
3.395200E-01
Stage1-vs-Stage3
3.117900E-02
Stage1-vs-Stage4
7.322000E-01
Stage2-vs-Stage3
2.530200E-01
Stage2-vs-Stage4
6.383400E-01
Stage3-vs-Stage4
1.075980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.106200E-01
Normal-vs-AfricanAmerican
5.949200E-01
Normal-vs-Asian
1.610840E-01
Caucasian-vs-AfricanAmerican
5.312000E-01
Caucasian-vs-Asian
4.235200E-01
AfricanAmerican-vs-Asian
3.866600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.916150E-01
Normal-vs-Female
2.947200E-01
Male-vs-Female
5.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.238800E-01
Normal-vs-Age(41-60Yrs)
3.845800E-01
Normal-vs-Age(61-80Yrs)
1.882980E-01
Normal-vs-Age(81-100Yrs)
2.057200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.005000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.026000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.496200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.250200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.566400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.346200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.242600E-01
Normal-vs-Daily Drinker
7.116800E-03
Normal-vs-Weekly Drinker
1.148250E-01
Normal-vs-Occasional Drinker
7.077000E-01
Normal-vs-Social Drinker
3.667400E-01
Non Drinker-vs-Daily Drinker
4.021800E-02
Non Drinker-vs-Weekly Drinker
5.707600E-01
Non Drinker-vs-Occasional Drinker
3.779800E-01
Non Drinker-vs-Social Drinker
5.982400E-01
Daily Drinker-vs-Weekly Drinker
1.959830E-01
Daily Drinker-vs-Occasional Drinker
3.660400E-02
Daily Drinker-vs-Social Drinker
1.717600E-02
Weekly Drinker-vs-Occasional Drinker
2.211000E-01
Weekly Drinker-vs-Social Drinker
3.297000E-01
Occasional Drinker-vs-Social Drinker
6.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.042000E-01
Normal-vs-Grade 2
7.397800E-03
Normal-vs-Grade 3
1.661780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.439800E-01
Grade 1-vs-Grade 3
3.239800E-01
Grade 1-vs-Grade 4
2.042000E-01
Grade 2-vs-Grade 3
3.972000E-01
Grade 2-vs-Grade 4
7.397800E-03
Grade 3-vs-Grade 4
1.661780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.123700E-02
Normal-vs-NonDiabetic
2.106400E-01
Diabetic-vs-NonDiabetic
5.795800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.015840E-01
Normal-vs-NoPancreatitis
1.997570E-01
Pancreatitis-vs-NoPancreatitis
8.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.765800E-01
Normal-vs-N1
1.734830E-01
N0-vs-N1
8.653000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.295200E-01
Normal-vs-TP53-NonMutant
4.296800E-01
TP53-Mutant-vs-TP53-NonMutant
9.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
